ArticleCancer2018

Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.

Katelyn M Atkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.